AN2 Therapeutics, Inc. (ANTX): 8-K filed Jun 9, 2026

Form type

8-K

Filing date

Jun 9, 2026

Accession number

0001193125-26-262264

Filer

AN2 Therapeutics, Inc. (CIK 1880438)